Disruption of the ETC supercomplexes with MitoTam can increase the therapeutic efficacy of reactive oxygen species (ROS)-inducing chemotherapeutics in C92D mutant Ndufs1 knock-in A549 cells or metastatic H1299 lung cancer cells, compared to parental A549 cancer cells. This evidence concerns the gene NDUFS1 and lung carcinoma.